Correlation between Wnt signaling and T-cell infiltration in high-grade serous ovarian cancer

被引：1

作者：

Goldsberry, W. ^{[1
]}

Phillips, R. A., III ^{[2
]}

Montgomery, A. M. ^{[1
]}

Katre, A. A. ^{[1
]}

Doo, D. W. ^{[1
]}

Norian, L. A. ^{[1
]}

Randall, T. ^{[1
]}

Yemelyanova, A. ^{[1
]}

Cooper, S. J. ^{[2
]}

Arend, R. C. ^{[1
]}

机构：

[1] Univ Alabama Birmingham, Birmingham, AL USA

[2] HudsonAlpha Inst Biotechnol, Huntsville, AL USA

来源：

GYNECOLOGIC ONCOLOGY | 2019年 / 154卷

关键词：

D O I：

10.1016/j.ygyno.2019.04.170

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1239

引用

页码：72 / 72

页数：1

共 50 条

[31] THE ROLE OF WNT SIGNALING ON T-CELL INFILTRATION IN GLIOBLASTOMA [J].

Tiwary, Shweta ;

Wei, Jun ;

Ezhilasaran, Rave ;

Sulman, Erik ;

Huang, Suyun ;

Ferguson, Sherise .

NEURO-ONCOLOGY, 2018, 20 :122-123

[32] Developing unsupervised drug response profiles to cluster high grade serous ovarian cancer cell lines and personalise the treatment of high-grade serous ovarian cancer [J].

Sun, Yu ;

Wang, Yangyang ;

Umbreen, Syed ;

Pepperrell, Benjamin ;

Ali, Ahlam ;

Buckley, Niamh ;

Furlong, Fiona .

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_3) :A53-A53

[33] Stable expansion of high-grade serous ovarian cancer organoids requires a low-Wnt environment [J].

Hoffmann, Karen ;

Berger, Hilmar ;

Kulbe, Hagen ;

Thillainadarasan, Sukanija ;

Mollenkopf, Hans-Joachim ;

Zemojtel, Tomasz ;

Taube, Eliane ;

Darb-Esfahani, Silvia ;

Mangler, Mandy ;

Sehouli, Jalid ;

Chekerov, Radoslav ;

Braicu, Elena, I ;

Meyer, Thomas F. ;

Kessler, Mirjana .

EMBO JOURNAL, 2020, 39 (06)

[34] Effect of chemotherapy on immune infiltration status and immune pathway activation in high-grade serous ovarian cancer [J].

LaVigne, K. ;

Jimenez-Sanchez, A. ;

Cybulska, P. ;

Chi, D. S. ;

Park, K. J. ;

Walther, T. ;

Miller, M. ;

Snyder, A. .

GYNECOLOGIC ONCOLOGY, 2018, 149 :53-53

[35] Principles of dormancy evident in high-grade serous ovarian cancer [J].

Trevor G. Shepherd ;

Frederick A. Dick .

Cell Division, 17

[36] The peritoneal tumour microenvironment of high-grade serous ovarian cancer [J].

Leinster, D. Andrew ;

Kulbe, Hagen ;

Everitt, Gemma ;

Thompson, Richard ;

Perretti, Mauro ;

Gavins, Felicity N. E. ;

Cooper, Dianne ;

Gould, David ;

Ennis, Darren P. ;

Lockley, Michelle ;

McNeish, Iain A. ;

Nourshargh, Sussan ;

Balkwill, Frances R. .

JOURNAL OF PATHOLOGY, 2012, 227 (02) :136-145

[37] Centrosomes - The Achilles' heel of high-grade serous ovarian cancer? [J].

Chandrasekaran, G. ;

Hall, D. ;

Vias, M. ;

Brenton, J. D. ;

Gergely, F. .

MOLECULAR BIOLOGY OF THE CELL, 2015, 26

[38] Determinants of resistance and response in high-grade serous ovarian cancer [J].

Bowtell, David D. L. .

CLINICAL CANCER RESEARCH, 2016, 22

[39] Novel strategies for targeting high-grade serous ovarian cancer [J].

Perets, Ruth ;

Wyant, Gregory A. ;

Ohman, Anders W. ;

Setlur, Sunita R. ;

Crum, Christopher P. ;

Drapkin, Ronny ;

Dinulescu, Daniela M. .

CLINICAL CANCER RESEARCH, 2015, 21

[40] Mechanisms of Drug Resistance in High-Grade Serous Ovarian Cancer [J].

Freimund, Alison E. ;

Beach, Jessica A. ;

Christie, Elizabeth L. ;

Bowtell, David D. L. .

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2018, 32 (06) :983-+

← 1 2 3 4 5 →